Last $105.96 USD
Change Today +0.03 / 0.03%
Volume 22.2M
GILD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Xetra
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter B. Dervan Ph.D.

Member of the Scientific Advisory Board, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 3 different organizations across 4 different industries.

See Board Relationships
68--

Background*

Dr. Peter B. Dervan, Ph.D. served as Chairman, Division of Chemistry and Chemical Engineering at the California Institute of Technology until 1999. Dr. Dervan is a Founding Member of Gilead Sciences Inc., and which he joined it in August 1987. He has been a Member of the Scientific Advisory Board at Gilead Sciences Inc., since August 1987. He serves as a Director of GeneSoft. He serves as a Member of the Scientific Advisory Board at GeneSoft and the Robert A. Welch Foundation. ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

1997-2011
Former Director, Chairman of Nominating and Corporate Governance Committee, Chairman of Nominating and Corporate Governance Committee, Director, Member of Special Transition Committee, Member of Organization and Compensation Committee and Member of Organization and Compensation Committee
2014-Present
Trustee

Education*

PhD 1972
Yale University
Bachelor's Degree 1967
Boston College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $105.96 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.